International Journal of Cardiology
Volume 139, Issue 2 , Pages 181-186 , 4 March 2010

Influence of atenolol on coronary artery spasm after acute myocardial infarction in a Japanese population

Received 12 May 2008 ,Revised 13 August 2008 ,Accepted 12 October 2008.

References 

  1. Jafri SM, Khaja F, McFarland T, et al. Efficacy of propranolol therapy after acute myocardial infarction related to coronary anatomy and left ventricular function. Am J Cardiol. 1987;60:976–980
  2. Kernis SJ, Harjai KJ, Stone GW, et al. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?. J Am Coll Cardiol. 2004;43:1773–1779
  3. Ishikawa K, Miyataka M, Kimura A, et al. Beta-blockers prevent cardiac events in Japanese patients with myocardial infarction. Circ J. 2004;68:59–67
  4. Wienbergen H, Zeymer U, Gitt AK, et al. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction. Am J Cardiol. 2007;99:1208–1211
  5. Basu S, Senior R, Raval U, van der Does R, Bruckner T, Lahiri A. Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial. Circulation. 1997;96:183–191
  6. Poulsen SH, Jensen SE, Egstrup K. Effects of long-term adrenergic beta-blockade on left ventricular diastolic filling in patients with acute myocardial infarction. Am Heart J. 1999;138:710–720
  7. Senior R, Basu S, Kinsey C, Schaeffer S, Lahiri A. Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction. Am Heart J. 1999;137:646–652
  8. Pristipino C, Beltrame JF, Finocchiaro ML, et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation. 2000;101:1102–1108
  9. The Japanese Beta-blockers and Calcium Antagonists Myocardial Infarction (JBCMI) investigators. Comparison of the effects of beta blockers and calcium antagonists on cardiovascular events after acute myocardial infarction in Japanese subjects. Am J Cardiol. 2004;93:969–973
  10. Robertson RM, Wood AJJ, Vaughn WK, Robertson D. Exacerbation of vasotonic angina pectoris by propranolol. Circulation. 1982;65:281–285
  11. Tilmant PY, Lablanche JM, Francois A, Thieuleux A, Dupuis BA, Bertrand ME. Detrimental effect of propranolol in patients with coronary arterial spasm countered by combination with diltiazem. Am J Cardiol. 1983;52:230–233
  12. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol. 1999;33:1442–1452
  13. Mongiardo R, Finocchiaro ML, Beltrame J, et al. Low incidence of serotonin-induced occlusive coronary artery spasm in patients with recent myocardial infarction. Am J Cardiol. 1996;78:84–87
  14. Nikolaou K, Knez A, Rist C, et al. Accuracy of 64-MDCT in the diagnosis of ischemic heart disease. Am J Roentgenol. 2006;187:111–117
  15. Leber AW, Knez A, von Ziegler F, et al. Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: a comparative study with quantitative coronary angiography and intravascular ultrasound. J Am Coll Cardiol. 2005;46:147–154
  16. Sueda S, Ochi N, Kawada H, et al. Frequency of provoked coronary vasospasm in patients undergoing coronary arteriography with spasm provocation test of acetylcholine. Am J Cardiol. 1999;83:1186–1190
  17. Sueda S, Kohno H, Fukuda H, et al. Frequency of provoked coronary spasms in patients undergoing coronary arteriography using a spasm provocation test via intracoronary administration of ergonovine. Angiology. 2004;55:403–411
  18. Suzuki Y, Tokunaga S, Ikeguchi S, et al. Induction of coronary artery spasm by intracoronary acetylcholine: comparison with intracoronary ergonovine. Am Heart J. 1992;124:39–47
  19. Svendsen TL. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity. J Cardiovasc Pharmacol. 1983;5(Suppl 1):S21–25
  20. Frishman WH. Clinical significance of beta 1-selectivity and intrinsic sympathomimetic activity in a beta-adrenergic blocking drug. Am J Cardiol. 1987;59:33F–37F
  21. Kazanietz MG, Enero MA. Desensitization of the beta-2 adrenoceptor-mediated vasodilation in rat aorta after prolonged treatment with the beta-2 adrenoceptor agonist clenbuterol. J Pharmacol Exp Ther. 1990;252:758–764
  22. Pfisterer M, Cox JL, Granger CB, et al. Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol. 1998;32:634–640
  23. Coats AJ. Ethical authorship and publishing. Int J Cardiol. 2009;131:149–150

PII: S0167-5273(08)01092-9

doi: 10.1016/j.ijcard.2008.10.017

International Journal of Cardiology
Volume 139, Issue 2 , Pages 181-186 , 4 March 2010

Article Tools

* Image Usage & Resolution